116 related articles for article (PubMed ID: 9855702)
1. Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Int J Mol Med; 1998 Sep; 2(3):301-7. PubMed ID: 9855702
[TBL] [Abstract][Full Text] [Related]
2. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
[TBL] [Abstract][Full Text] [Related]
3. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
6. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
Maciejewski B; Withers HR; Taylor JM; Hliniak A
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in oral cancer.
Miyoshi Y; Tsukinoki K; Imaizumi T; Yamada Y; Ishizaki T; Watanabe Y; Sasakura Y; Lin Y; Hosaka M; Kubota Y
Oral Oncol; 1999 May; 35(3):283-9. PubMed ID: 10621849
[TBL] [Abstract][Full Text] [Related]
8. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy.
Kao GD; Devine P; Mirza N
Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):873-6. PubMed ID: 10448734
[TBL] [Abstract][Full Text] [Related]
9. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
10. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx.
Fijuth J; Mazeron JJ; Le Péchoux C; Piedbois P; Martin M; Haddad E; Calitchi E; Pierquin B; Le Bourgeois JP
Int J Radiat Oncol Biol Phys; 1992; 24(1):59-64. PubMed ID: 1512164
[TBL] [Abstract][Full Text] [Related]
11. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
12. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
[TBL] [Abstract][Full Text] [Related]
13. Oral cavity and oropharynx tumors.
Stambuk HE; Karimi S; Lee N; Patel SG
Radiol Clin North Am; 2007 Jan; 45(1):1-20. PubMed ID: 17157621
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
15. [Detection and effect of telomerase activity in oral mucosal squamous cell carcinoma].
Yao H; Wu B; Wu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Jul; 35(4):269-70. PubMed ID: 11780506
[TBL] [Abstract][Full Text] [Related]
16. Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma.
Zelefsky MJ; Gaynor J; Kraus D; Strong EW; Shah JP; Harrison LB
Am J Surg; 1996 Feb; 171(2):258-61; discussion 262. PubMed ID: 8619464
[TBL] [Abstract][Full Text] [Related]
17. Radiation Therapy for Oral Cavity and Oropharyngeal Cancers.
Lin A
Dent Clin North Am; 2018 Jan; 62(1):99-109. PubMed ID: 29126497
[TBL] [Abstract][Full Text] [Related]
18. Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Ries JC; Hassfurther E; Steininger H; Kloss FR; Wiltfang J; Girod SC; Neukam FW
Anticancer Res; 2001; 21(2A):1057-63. PubMed ID: 11396140
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
20. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
